Reporter

Achilles’ heel for kidney cancer

The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.

Personalized pain management

Understanding how natural brain chemicals with pain-relieving properties interact with administered opioids may guide personalized approaches for pain management.

Protein loss promotes cell migration

The protein kinase STK17A plays a novel role in epithelial cells and its loss may contribute to colorectal cancer invasion and metastasis, Vanderbilt researchers report.

Kyla Terhune, MD, MBA

Terhune named to senior GME leadership role

Kyla Terhune, MD, MBA, associate professor Surgery and director of the Surgery Residency Training Program in the Section of Surgical Sciences, has been named Vice President for Educational Affairs for Vanderbilt University Medical Center and Associate Dean for Graduate Medical Education for Vanderbilt University School of Medicine. Her appointment is effective July 1.

Gene identified that increases risk of antibiotic reaction

Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.

VUMC employees poised to Celebrate March 7 and 8

A chance to win seats at a Predators hockey game, updates on recent successes, a free meal, live music, patient stories and a Vanderbilt Health logo T-shirt for all attendees are just part of what’s in store at the employee appreciation event — Celebrate the Difference WE Make Every Day! — being held next week on March 7 and 8.

1 259 260 261 262 263 725